Wei‐Fen Xie

6.5k citations
116 papers · 4.3k indexed · h-index 38
Topics
Liver Disease Diagnosis and Treatment (33 papers)Liver physiology and pathology (32 papers)MicroRNA in disease regulation (11 papers)
Partner nations
ChinaUnited StatesSpain

In The Last Decade

Wei‐Fen Xie

110 papers receiving 4.3k citations

Peers

Wei‐Fen Xie
Comparison fields: 5 of 125
  • Molecular Biology 2.1k
  • Hepatology 1.2k
  • Epidemiology 1.0k
  • Cancer Research 999
  • Oncology 905
Replace Jens U. Marquardt with:
Jens U. Marquardt Germany
Satoshi Shimizu Japan
Hong‐Yang Wang China
Hayato Hikita Japan
Olivier Govaere Belgium
Frank Dombrowski Germany
Jesús M. Bañales Spain
Le‐Xing Yu China
Ja June Jang South Korea
Hitoshi Kohno Japan
Wei‐Fen Xie relative to Jens U. Marquardt Germany Jens U. Marquardt's profile →
Citations per field
00.5×1.5×
Jens U. Marquardt · 1×
Citations per year

Countries citing papers authored by Wei‐Fen Xie

Since Specialization
Citations

This map shows the geographic impact of Wei‐Fen Xie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Fen Xie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Fen Xie more than expected).

Fields of papers citing papers by Wei‐Fen Xie

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Fen Xie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Fen Xie. The network helps show where Wei‐Fen Xie may publish in the future.

Co-authorship network of co-authors of Wei‐Fen Xie

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Fen Xie. A scholar is included among the top collaborators of Wei‐Fen Xie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Fen Xie. Wei‐Fen Xie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 11
3 6
4 8
5 2
6 1
7 3
8 7
9 14
10 1
11 37
12 92
13 6
14 88
15 181
16 0
17 69
18 194
19 1
20
[Inhibition of proliferation of hepatic stellate cells by taurine is mediated via regulating cell cycle proteins].
1

About Wei‐Fen Xie

Wei‐Fen Xie is a scholar working on Hepatology, Epidemiology and Cancer Research, having authored 116 papers that have together received 4.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (33 papers), Liver physiology and pathology (32 papers) and MicroRNA in disease regulation (11 papers). The work is most often cited by research in Hepatology (1.2k citations), Cancer Research (999 citations) and Oncology (905 citations). Wei‐Fen Xie has collaborated with scholars based in China, United States and Spain. Frequent co-authors include Yue-Xiang Chen, Beifang Ning, Jin Ding, Chuan Yin, Xin Zeng, Hongyang Wang, Xin Zhang, Xing Deng, Yong Lin and Jian Shi. Their work appears in journals such as Journal of Biological Chemistry, Nature Communications and Gastroenterology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026